Dr. Noel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Washington, DC 20007Phone+1 202-444-2223
Education & Training
- University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of Rochester Medical CenterResidency, Internal Medicine, 2008 - 2011
- Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
- DC State Medical License 2019 - 2026
- VA State Medical License 2021 - 2026
- MD State Medical License 2022 - 2025
- NY State Medical License 2010 - 2020
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Start of enrollment: 2017 Oct 06
- A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer Start of enrollment: 2021 Mar 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.Andrew H Ko, Joseph Chao, Marcus S Noel, Veena Shankaran, Davendra Sohal
Cancer Research Communications. 2025-02-01 - Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic Adenocarcinomas.Jerry Xiao, Reetu Mukherji, George Sidarous, Shravanthy Suguru, Marcus Noel
Cancers. 2025-01-22 - Clinician-to-clinician connectedness and access to gastric cancer surgery at National Cancer Institute-designated cancer centers.Nathan Aminpour, Vy Phan, Haijun Wang, James McDermott, Michelle Valentin
Journal of Gastrointestinal Surgery. 2024-09-01
Press Mentions
- Let’s Talk About: Pancreatic Cancer’s Impact on Black AmericansFebruary 4th, 2022
- ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GIJanuary 24th, 2022
- ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic CancerAugust 24th, 2021
- Join now to see all
Grant Support
- National Capital Area (NCA) Minority/Underserved NCORPGEORGETOWN UNIVERSITY2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: